全球犬关节炎治疗市场 – 行业趋势及 2029 年预测

市场分析和见解

过去几年，随着人们收养宠物和提高对宠物健康的认识，市场规模迅速扩大。此外，在预测期内，市场预计将经历巨大增长。

• Data Bridge Market Research分析，在2022年至2029年的预测期内，犬关节炎治疗市场将以4.5%的复合年增长率增长。预测期内，“干细胞疗法”占犬关节炎治疗市场中最大的治疗细分市场。

市场定义

犬关节炎是一种退行性关节疾病，会影响狗，并因过度摩擦、软骨损伤和长期关节疾病而导致其关节发炎。肥胖、骨骼发育不良和意外伤害是宠物患犬关节炎的一些原因。宠物关节炎的症状包括关节不适、僵硬、肿胀和疼痛，以及患处不断摩擦和形成不必要的唾液斑。

犬关节炎治疗 市场动态

驱动程序

• 关节炎及相关疾病病例不断增加

关节炎和相关疾病病例的增加将导致治疗市场增长率的扩大。此外，宠物肥胖在世界各地越来越普遍。肥胖与狗的骨关节炎直接相关，这会导致由于过多的脂肪和体重导致关节负荷增加而难以活动。

此外，关节不稳定、韧带断裂、长期关节疼痛、关节过度摩擦（增加患关节炎 的风险）也是推动市场增长的一个增长决定因素。此外，犬类（狗）的饲养量增加将进一步促进犬关节炎治疗市场的增长。

此外，治疗的普及将扩大犬关节炎治疗市场。其他因素，如对有效治疗程序的需求增加，以及宠物可用技术的进步，将对犬关节炎治疗市场的增长率产生积极影响。

机会

Moreover, the fast approval for veterinary regenerative medicine and veterinary therapeutic drugs by FDA to repair the damaged tissues will boost new opportunities for the market's growth rate. Also, the increase in awareness regarding canine health will escalate the growth rate canine arthritis treatment market in future.

Restraints/Challenges

However, the lack of professional for the treatment of canine arthritis will impede the growth rate of canine arthritis treatment market. Additionally, the factors such as the expensive treatment and stringent drug approval process are estimated to hinder the market’s growth.

This canine arthritis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on canine arthritis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

The canine arthritis is majorly caused by the obesity, failure of bone development, and accidental injuries in pets. According to the studies, the canine arthritis basically affects 20% of dogs over 1 year of age in North America.

Canine arthritis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Canine Arthritis Treatment Market

The outbreak of the COVID-19 pandemic has resulted in the implementation of strict lockdowns and isolation regulations across the globe, which further led to the restrictions in the non-essential vet visits. Moreover, the canine arthritis treatment market was however affected severely by the postponement of the medical operations across the globe. However, the emergence of the COVID-19 pandemic on the other hand, has increased the adoption of pets and foster applications which is projected to aid the industry growth in the forecast period.

Recent Developments

• In September 2020, The Committee for Medicinal Products for Veterinary Use (CVMP) granted Zoetis a variation in terms of marketing authorization for the veterinary medicinal product Cytopoint, which involves adding a new therapeutic indication for the treatment of pruritus associated with allergic dermatitis in dogs.

Global Canine Arthritis Treatment Market Scope

The canine arthritis treatment market is segmented on the basis of type, route of administration, treatment, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Surgery
• Drugs
• Others

On the basis of type, canine arthritis treatment market is segmented into surgery, drugs and others.

Route of Administration

• Oral
• Parenteral
• Others

On the basis of route of administration, canine arthritis treatment market is segmented into oral, parenteral and others.

Treatment

• Non-steroidal anti-inflammatory Medications (NSAIDs)
• Opioids
• Stem Cell Therapy
• Allogeneic Stem Cells
• Autologous Stem Cells

On the basis of treatment, the canine arthritis treatment market is segmented into non-steroidal anti-inflammatory medications (NSAIDS), opioids, stem cell therapy, allogeneic stem cells and autologous stem cells. Stem cell therapy is projected to grow at a significant amount within the forecasted period.

End-Users

• Hospitals
• Speciality Clinics
• Others

On the basis of end-users, the canine arthritis treatment market is segmented into hospitals, speciality clinics and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

On the basis of distribution channel, the canine arthritis treatment market is segmented into hospital pharmacy, retail pharmacy and others.

Canine Arthritis Treatment Market Regional Analysis/Insights

The canine arthritis treatment market is analyzed and market size insights and trends are provided by country, type, route of administration, treatment, end-users and distribution channel as referenced above.

The countries covered in the canine arthritis treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

北美在市场份额和市场收入方面占据犬关节炎治疗市场的主导地位，并将在预测期内继续保持主导地位。这是由于该地区动物和兽医医院的采用率不断提高，以及消费者在兽医方面的支出不断增加。另一方面，预计亚太地区在预测期内的增长率最高，这是因为该地区犬关节炎的患病率不断上升、治疗和诊断方法的可及性不断提高，以及动物健康意识计划不断加强。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。

竞争格局和犬关节炎治疗 市场份额分析

犬关节炎治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对犬关节炎治疗市场的关注有关。

犬关节炎治疗市场的一些主要参与者包括勃林格殷格翰国际有限公司、第一三共有限公司、Thorne、NUTRI-VET、Liquid Health、American Regent, Inc.、DSM、Elanco、Zoetis、nationalhogfarmer、Ceva、Novasep、BASF SE、Bayer AG 和 Matsun Nutrition 等。

SKU-52806